Ocular Therapeutix/$OCUL
About Ocular Therapeutix
Ticker
Industry
Employees
OCUL Metrics
$1.2B
-
-$1.27
1.20
-
Price and volume
Market cap
$1.2B
Beta
1.2
52-week high
$11.31
52-week low
$3.76
Average daily volume
850K
Financial strength
Current ratio
13.009
Quick ratio
12.593
Long term debt to equity
20.853
Total debt to equity
21.341
Interest coverage (TTM)
-9.77%
Management effectiveness
Return on assets (TTM)
-27.36%
Return on equity (TTM)
-96.89%
Valuation
Price to revenue (TTM)
17.572
Price to book
3.5
Price to tangible book (TTM)
3.5
Price to free cash flow (TTM)
-9.054
Growth
Revenue change (TTM)
6.45%
Earnings per share change (TTM)
17.07%
3-year revenue growth (CAGR)
16.80%
3-year earnings per share growth (CAGR)
-13.54%
What the Analysts think about OCUL
Analyst Ratings
OCUL Financial Performance
Income Statement
Q3 24
QoQ growth
$37B
-39.75%
$45B
107.52%
37.65%
6.78%
OCUL Earnings Performance
Earnings per share (EPS)
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
$3.69
$2.85
$2.45
$2.42
-
$3.55
$2.61
$2.05
$2.31
$3.94
3.94%
9.20%
19.51%
4.63%
-
OCUL News
FAQs
What’s the current market cap for Ocular Therapeutix stock?
What is the P/E ratio for Ocular Therapeutix stock?
Does Ocular Therapeutix stock pay dividends?
No, Ocular Therapeutix (OCUL) stock does not pay dividends to its shareholders as of January 15, 2025.
When is the next Ocular Therapeutix dividend payment date?
Ocular Therapeutix (OCUL) stock does not pay dividends to its shareholders.
What is the beta indicator for Ocular Therapeutix?
Ocular Therapeutix (OCUL) has a beta rating of 1.2. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.